Celiac disease in North Italian patients with autoimmune Addison's disease

Objective: Patients with autoimmune Addison's disease (AAD) are prone to develop other autoimmune manifestations. An increased prevalence of celiac disease (CD) has recently been demonstrated in Northern European patients with AAD. IgA deficiency is the most frequent type of immunodeficiency among humans and is present in about one in every 600 individuals in the population. IgA deficiency is frequent in patients with other autoimmune diseases, but data concerning AAD are still unavailable. Design: The aim was to define the prevalence of Cl) and of IgA deficiency in a group of Italian patients with AAD. Methods: One hundred and nine patients with AAD were enrolled and examined for tissue transglutaminase autoantibodies of the IgA class, circulating levels of IgA and adrenal cortex antibodies. Results: Two (1.8%) of the patients were affected by already diagnosed CD and were already on a gluten-free diet. Out of the remaining 107 patients, four (3.7%) were round to be positive for IgA antibodies to human tissue transglutaminase. Three of the four patients who were positive for tissue transglutaminase autoantibodies agreed to undergo endoscopy and duodenal biopsies and, in one, a latent form of CD was identified. The clinical, silent or latent Form of CD was present in six out of 109 (5.4%). This prevalence was significantly higher (P = 0.0001) than that reported for the Northern Italian population which was equal to 0.063%, Specifically, CD was present in 12.5% of the autoimmune polyglandular syndrome (APS) type 1. cases, in lour out of 60 (6.7%) of the APS type 2 cases and in one out of 40 (2.5'%) of the isolated AAD cases. IgA deficiency was present in two out of 109 patients (1.8%). all of whom had normal IgG anti-gliadin. Autoantibodies to the adrenal cortex were detected in 81 out of 1.09 patients (74.3%). Conclusions: In patients with AAD there is a high prevalence of both CD and IgA deficiency. Consequently, it is important to screen for CD with tissue transglutaminase autoantibodies of the IgA class and for IgA levels.